Pfizer, BioNTech Ask FDA for Full Approval of Covid-19 Vaccine
By Joseph Walker
May 7, 2021 3:28 pm ET
The Wall Street Journal (5/7, Subscription Publication) reported Pfizer and BioNTech have asked the FDA for full approval of their COVID-19 vaccine. The companies requested a priority review for the vaccine.
The Hill (5/7) reported if the agency gives full approval to the vaccine, it “could be given to patients after the public health emergency is declared over.”
FURTHER READING
Pfizer Plans To Request COVID-19 Vaccine EUA For Ages 2-11 In September